Pure red cell aplasia after 13 years of sodium valproate, and bone marrow suppression after 17 years of carbamazepine

PLoS Medicine

Volumn 1, Issue 2, 2004, Pages 125-127

  The, Tiong ^a   Kolla, Ratnavalli ^b   Dawkins, Fitzroy ^b   Trouth, Annapurni Jayam ^b  

^a SAINT PETER S UNIVERSITY HOSPITAL   (United States)

^b HOWARD UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CARNITINE; CLONAZEPAM; ERYTHROPOIETIN; HYDROCORTISONE; LEVOTHYROXINE; LEVOTHYROXINE SODIUM; MEGESTROL ACETATE; OXCARBAZEPINE; PREDNISONE; VALPROIC ACID; ZONISAMIDE; ANTICONVULSIVE AGENT;

ADRENAL INSUFFICIENCY; ADULT; ANAMNESIS; ANOREXIA; ARTICLE; BONE MARROW SUPPRESSION; CASE REPORT; CLINICAL FEATURE; DRUG WITHDRAWAL; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; HYPOTHYROIDISM; LABORATORY TEST; LOW DRUG DOSE; MIXED SEIZURE; PURE RED CELL ANEMIA; BONE MARROW; CHEMICALLY INDUCED DISORDER; DOWN SYNDROME; DRUG ADMINISTRATION; DRUG EFFECT; PHYSIOLOGY; TIME;

ADULT; ANTICONVULSANTS; BONE MARROW; CARBAMAZEPINE; DOWN SYNDROME; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; RED-CELL APLASIA, PURE; TIME FACTORS; VALPROIC ACID;

EID: 15744367155     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0010051     Document Type: Article

References (10)

1. Farkas V, Szabo M, Renyi I, Kohlheb O, Benninger C (2000) Temporary pure red-cell aplasia during valproate monotherapy: Clinical observations and spectral electroencephalographic aspects. J Child Neurol 15: 485-487.
2. Anzai K, Kitajima H, Kubo M (1994) A case of pure red cell aplasia associated with sodium valproate therapy. Rinsho Ketsueki 35: 286-290.
3. Kawauchi K, Miyano T, Ikeda Y, Tateoka N, Kasai M, et al. (1989) A report of a case with pure red cell aplasia induced by sodium valproate. Acta Paediatr Jpn 31: 615-619.
4. Hirose Y, Konda S (1984) Depakene-induced intravascular hemolysis and pure red cell aplasia. Nippon Ketsueki Gakkai Zasshi 47: 1366-1370.
5. MacDougall LG (1982) Pure red cell aplasia associated with sodium valproate therapy. JAMA 247: 53-54.
6. Tohen M, Castillo J, Baldessarini RJ, Zarate C Jr, Kando JC (1995) Blood dyscrasias with carbamazepine and valproate: A pharmacoepidemiological study of 2,228 patients at risk. Am J Psych 152: 413-418.
7. Sobotka JL, Alexander B, Cook BL (1990) A review of carbamazepine's hematologic reactions and monitoring recommendations. DICP 24: 1214-1219.
8. Pavithran K, Raji NL (2003) Aplastic anemia in Down's syndrome. Am J Hematol 73: 213.
9. Tagawa T, Sumi K, Uno R, Itagaki Y, Fujii F, et al. (1997) Pure red cell aplasia during carbamazepine monotherapy. Brain Dev 19: 300-302.
10. Abbott Laboratories (2004) Depakene product information. In: Physicians' desk reference, 58th ed. Montvale (New Jersey): Thomson PDR. pp. 425-430.